• Contact us
  • Customer support
  • Login
  • Home
  • Technology
    • Introduction to Ex Vivo Lung Perfusion
    • The Ex Vivo Lung Perfusion Process
    • Clinical
    • Protocols
    • Starting your clinical EVLP program
    • Articles about EVLP
    • EVLP with Manual method
    • EVLP with XPS™
    • Training and workshops
    • Patents
  • Products
    • Our Products
    • XPS™
    • XPS Disposable Lung Kit™
    • STEEN Solution™
    • PERFADEX® Plus
    • XVIVO
      Organ Chamber™
    • XVIVO
      Lung Cannula Set™
    • Instruction for Use
  • Knowledge
    • NOVEL Lung Trial
    • Literature
    • Insights
  • Media
    • Videos
    • Webinars
    • Establishing a successful EVLP program
  • About us
    • About XVIVO
    • History
    • Our market
    • News
    • Career
    • Working at XVIVO
  • Corporate
    • Corporate
    • The share
      • Info
      • Ownership structure
      • Insiders (PDMRs)
    • Press releases
      • 2023
      • 2022
      • 2021
      • 2020
      • 2019
      • 2018
      • 2017
      • 2016
      • 2015
      • 2014
      • 2013
      • 2012
    • Financial calendar
    • Financial reports
    • Financial reports – ESEF
    • Prospectus and material offerings
      • Material offerings
      • Prospectus
    • Financial presentations
      • Capital Markets Day
      • Earnings calls
    • Corporate governance
      • Article of Association
      • General meetings
      • Board of Directors
      • Senior Management
      • Auditors
      • Board Committees
      • Board and Senior Management share holdings
      • Guidelines for remuneration
      • Nomination Committee
      • Corporate Governance Reports
    • Analyst Coverage
    • Code of Conduct
    • Environmental Policy
    • Code of Conduct for Suppliers
    • Privacy policy
    • Contact us
    • Subscribe
    • Thank you
    • Error
XVIVO
  • Contact us
  • Customer support
  • Home
  • Technology
    • Introduction to Ex Vivo Lung Perfusion
    • The Ex Vivo Lung Perfusion Process
    • Clinical
    • Protocols
    • Starting your clinical EVLP program
    • Articles about EVLP
    • EVLP with Manual method
    • EVLP with XPS™
    • Training and workshops
    • Patents
  • Products
    • Our Products
    • XPS™
    • XPS Disposable Lung Kit™
    • STEEN Solution™
    • PERFADEX® Plus
    • XVIVO
      Organ Chamber™
    • XVIVO
      Lung Cannula Set™
    • Instruction for Use
  • Knowledge
    • NOVEL Lung Trial
    • Literature
    • Insights
  • Media
    • Videos
    • Webinars
    • Establishing a successful EVLP program
  • About us
    • About XVIVO
    • History
    • Our market
    • News
    • Career
    • Working at XVIVO
  • Corporate
    • Corporate
    • The share
      • Info
      • Ownership structure
      • Insiders (PDMRs)
    • Press releases
      • 2023
      • 2022
      • 2021
      • 2020
      • 2019
      • 2018
      • 2017
      • 2016
      • 2015
      • 2014
      • 2013
      • 2012
    • Financial calendar
    • Financial reports
    • Financial reports – ESEF
    • Prospectus and material offerings
      • Material offerings
      • Prospectus
    • Financial presentations
      • Capital Markets Day
      • Earnings calls
    • Corporate governance
      • Article of Association
      • General meetings
      • Board of Directors
      • Senior Management
      • Auditors
      • Board Committees
      • Board and Senior Management share holdings
      • Guidelines for remuneration
      • Nomination Committee
      • Corporate Governance Reports
    • Analyst Coverage
    • Code of Conduct
    • Environmental Policy
    • Code of Conduct for Suppliers
    • Privacy policy
    • Contact us
    • Subscribe
    • Thank you
    • Error
  • Corporate
  • The share
    • Info
    • Ownership structure
    • Insiders (PDMRs)
  • Press releases
    • 2023
    • 2022
    • 2021
    • 2020
    • 2019
    • 2018
    • 2017
    • 2016
    • 2015
    • 2014
    • 2013
    • 2012
  • Financial calendar
  • Financial reports
  • Financial reports – ESEF
  • Prospectus and material offerings
    • Material offerings
    • Prospectus
  • Financial presentations
    • Capital Markets Day
    • Earnings calls
  • Corporate governance
    • Article of Association
    • General meetings
    • Board of Directors
    • Senior Management
    • Auditors
    • Board Committees
    • Board and Senior Management share holdings
    • Guidelines for remuneration
    • Nomination Committee
    • Corporate Governance Reports
  • Analyst Coverage
  • Code of Conduct
  • Environmental Policy
  • Code of Conduct for Suppliers
  • Privacy policy
  • Contact us
  • Subscribe
  • Thank you
  • Error

Press releases 2016

  • All press releases
  • Regulatory Press Releases
2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012
2016-11-21 17:00
News
IR
Swedish
Corporate Information
Other Corporate Information
XVIVO Perfusion har godkänts för notering på Nasdaq Stockholm och offentliggör prospekt
2016-11-21 17:00
News
IR
English
Corporate Information
Other Corporate Information
XVIVO Perfusion has been approved for listing on Nasdaq Stockholm and publishes prospectus
2016-10-27 17:15
News
IR
English
Regulatory
MAR
Corporate Information
Other Corporate Information
Clarification of news about two LS™ contract signed in Spain
2016-10-27 17:15
News
IR
Swedish
Regulatory
MAR
Corporate Information
Other Corporate Information
Förtydligande angående två LS™ kontrakt i Spanien
2016-10-27 08:30
News
IR
English
Regulatory
MAR
Report
Interim
Q3
XVIVO Perfusion Interim report January – September 2016
2016-10-27 08:30
News
IR
Swedish
Regulatory
MAR
Report
Interim
Q3
Delårsrapport januari – september 2016
2016-10-27 07:30
News
IR
Swedish
Regulatory
MAR
Corporate Information
Other Corporate Information
Två LS™ kontrakt i Spanien
2016-10-27 07:30
News
IR
English
Regulatory
MAR
Corporate Information
Other Corporate Information
Two LS™ contract signed in Spain
2016-10-21 10:00
News
IR
Swedish
Corporate Information
Other Corporate Information
Telefonkonferens avseende delårsrapport
2016-10-21 10:00
News
IR
English
Corporate Information
Other Corporate Information
Conference call on Interim Report
2016-09-20 14:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Nomination Committee
Valberedning i XVIVO Perfusion AB (publ)
2016-09-20 14:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Nomination Committee
Election Committee of XVIVO Perfusion AB (publ)
2016-07-15 08:30
News
IR
English
Regulatory
VPML
Report
Interim
Q2
XVIVO Perfusion Interim report January – June 2016
2016-07-15 08:30
News
IR
Swedish
Regulatory
VPML
Report
Interim
Q2
Delårsrapport januari - juni 2016
2016-07-15 07:30
News
IR
Swedish
Regulatory
MAR
Corporate Information
Other Corporate Information
Förlängd acceptperiod i XVIVO Perfusions bud på Vivoline Medical avslutad
2016-07-15 07:30
News
IR
English
Regulatory
MAR
Corporate Information
Other Corporate Information
Extension of the acceptance period of XVIVO Perfusion’s public offer on Vivoline Medical has ended
2016-07-08 09:00
News
IR
English
Corporate Information
Other Corporate Information
Conference call on Interim Report
2016-07-08 09:00
News
IR
Swedish
Corporate Information
Other Corporate Information
Telefonkonferens avseende delårsrapport
2016-07-08 08:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
Teckningsoptionsprogrammet fulltecknat
2016-07-08 08:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
Share warrant program fully subscribed
2016-06-22 08:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
Lungcancerpatient ges kemoterapi genom In Vivo Lung perfusion med STEEN Solution™
2016-06-22 08:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
Lung Cancer Patient given Chemotherapy through In Vivo Lung Perfusion with STEEN Solution™
2016-06-21 07:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
XVIVO Perfusion förlänger acceptperioden avseende budet på Vivoline Medical
2016-06-21 07:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
XVIVO Perfusion extends the acceptance period for the public offer on Vivoline Medical
2016-06-17 08:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
XPS™ contract signed with leading hospital in Alabama
2016-06-17 08:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
XPS™ kontrakt med klinik i Alabama
2016-06-15 08:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
Första patienten i PrimECC studien inkluderad
2016-06-15 08:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
First patient in PrimECC study included
2016-06-08 07:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
XVIVO Perfusion declares the public offer on Vivoline Medical unconditional, announces the outcome and extends the acceptance period
2016-06-08 07:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
XVIVO Perfusion förklarar budet på Vivoline Medical ovillkorat, offentliggör utfallet och förlänger acceptperioden
2016-05-17 08:30
News
IR
English
Corporate Information
Other Corporate Information
Conference call regarding information on the offer made to Vivoline’s shareholders
2016-05-17 08:30
News
IR
Swedish
Corporate Information
Other Corporate Information
Telefonkonferens avseende Information angående Erbjudandet till Vivolines aktieägare
2016-05-10 14:00
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
XVIVO Perfusion published prospectus regarding the public offer to the holders of shares and warrants of series 2015/2016 in Vivoline Medical
2016-05-10 14:00
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
XVIVO Perfusion offentliggör prospekt avseende erbjudandet till ägare av aktier och teckningsoptioner av serie 2015/2016 i Vivoline Medical
2016-05-04 08:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
General meeting
Report of the AGM
Report from Annual General Meeting of XVIVO Perfusion AB (publ)
2016-05-04 08:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
General meeting
Report of the AGM
Kommuniké från årsstämma i XVIVO Perfusion AB (publ)
2016-04-26 08:30
News
IR
Swedish
Regulatory
Listing Regulation
Report
Interim
Q1
XVIVO Perfusion delårsrapport januari - mars 2016
2016-04-26 08:30
News
IR
English
Regulatory
Listing Regulation
Report
Interim
Q1
XVIVO Perfusion Interim report January – March 2016
2016-04-22 08:30
News
IR
English
Corporate Information
Other Corporate Information
Conference call on Interim Report
2016-04-22 08:30
News
IR
Swedish
Corporate Information
Other Corporate Information
Telefonkonferens avseende delårsrapport
2016-04-18 07:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
XVIVO Perfusion announces a recommended public offer to the holders of shares and warrants of series 2015/2016 in Vivoline Medical
2016-04-18 07:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
XVIVO Perfusion lämnar ett rekommenderat offentligt erbjudande till ägare av aktier och teckningsoptioner av serie 2015/2016 i Vivoline Medical
2016-04-15 08:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
XPS™ contract signed with leading hospital in Boston
2016-04-15 08:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
XPS™ kontrakt med klinik i Boston
2016-04-11 08:30
News
IR
Swedish
Regulatory
VPML
Report
Annual
Årsredovisning 2015
2016-04-11 08:30
News
IR
English
Regulatory
VPML
Corporate Information
Other Corporate Information
Annual Report 2015
2016-03-31 08:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
General meeting
Notice
Kallelse till årsstämma i XVIVO Perfusion AB (publ)
2016-03-31 08:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
General meeting
Notice
Annual General Meeting of XVIVO Perfusion AB (publ)
2016-02-24 08:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
XPS™ to be delivered to the first clinic in France
2016-02-24 08:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
XPS™ levereras till första kliniken i Frankrike
2016-02-16 08:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
PERFADEX® and STEEN Solution™ approved in Russia
2016-02-16 08:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
PERFADEX® och STEEN Solution™ godkända i Ryssland
2016-02-05 16:00
News
IR
Swedish
Corporate Information
Other Corporate Information
XVIVO Perfusion AB upptas till handel på Nasdaq First North Premier
2016-02-05 16:00
News
IR
English
Corporate Information
Other Corporate Information
XVIVO Perfusion AB admitted to trading on Nasdaq First North Premier
2016-02-04 08:30
News
IR
English
Regulatory
VPML
Report
Interim
Yearend
Report on operations 2015
2016-02-04 08:30
News
IR
Swedish
Regulatory
VPML
Report
Interim
Yearend
Bokslutskommuniké 2015
2016-01-29 08:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
XPS™ till Schweiz
2016-01-29 08:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
XPS™ to Switzerland
2016-01-28 08:30
News
IR
English
Corporate Information
Other Corporate Information
Conference call on Report on Operations 2015
2016-01-28 08:30
News
IR
Swedish
Corporate Information
Other Corporate Information
Telefonkonferens avseende bokslutskommuniké 2015
2016-01-07 08:30
News
IR
English
Corporate Information
Other Corporate Information
PrimECC has been granted CE mark
2016-01-07 08:30
News
IR
Swedish
Corporate Information
Other Corporate Information
PrimECC har erhållit CE-märke
2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012
2016-10-27 17:15
News
IR
English
Regulatory
MAR
Corporate Information
Other Corporate Information
Clarification of news about two LS™ contract signed in Spain
2016-10-27 17:15
News
IR
Swedish
Regulatory
MAR
Corporate Information
Other Corporate Information
Förtydligande angående två LS™ kontrakt i Spanien
2016-10-27 08:30
News
IR
English
Regulatory
MAR
Report
Interim
Q3
XVIVO Perfusion Interim report January – September 2016
2016-10-27 08:30
News
IR
Swedish
Regulatory
MAR
Report
Interim
Q3
Delårsrapport januari – september 2016
2016-10-27 07:30
News
IR
Swedish
Regulatory
MAR
Corporate Information
Other Corporate Information
Två LS™ kontrakt i Spanien
2016-10-27 07:30
News
IR
English
Regulatory
MAR
Corporate Information
Other Corporate Information
Two LS™ contract signed in Spain
2016-09-20 14:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Nomination Committee
Valberedning i XVIVO Perfusion AB (publ)
2016-09-20 14:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Nomination Committee
Election Committee of XVIVO Perfusion AB (publ)
2016-07-15 08:30
News
IR
English
Regulatory
VPML
Report
Interim
Q2
XVIVO Perfusion Interim report January – June 2016
2016-07-15 08:30
News
IR
Swedish
Regulatory
VPML
Report
Interim
Q2
Delårsrapport januari - juni 2016
2016-07-15 07:30
News
IR
Swedish
Regulatory
MAR
Corporate Information
Other Corporate Information
Förlängd acceptperiod i XVIVO Perfusions bud på Vivoline Medical avslutad
2016-07-15 07:30
News
IR
English
Regulatory
MAR
Corporate Information
Other Corporate Information
Extension of the acceptance period of XVIVO Perfusion’s public offer on Vivoline Medical has ended
2016-07-08 08:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
Teckningsoptionsprogrammet fulltecknat
2016-07-08 08:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
Share warrant program fully subscribed
2016-06-22 08:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
Lungcancerpatient ges kemoterapi genom In Vivo Lung perfusion med STEEN Solution™
2016-06-22 08:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
Lung Cancer Patient given Chemotherapy through In Vivo Lung Perfusion with STEEN Solution™
2016-06-21 07:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
XVIVO Perfusion förlänger acceptperioden avseende budet på Vivoline Medical
2016-06-21 07:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
XVIVO Perfusion extends the acceptance period for the public offer on Vivoline Medical
2016-06-17 08:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
XPS™ contract signed with leading hospital in Alabama
2016-06-17 08:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
XPS™ kontrakt med klinik i Alabama
Next
About us

Founded in 1998, XVIVO is the only medical technology company dedicated to extending the life of all major organs so transplant teams around the world can save more lives.
Our solutions allow leading clinicians and researchers to push the boundaries of transplantation medicine.
XVIVO is headquartered in Gothenburg, Sweden, and has offices and research sites on three continents. The company is listed on Nasdaq.

Contact

Swedish Office
XVIVO Perfusion AB
Box 53015
SE-400 14 Göteborg
Sweden

Phone: +46 31 788 21 50
Fax: +46 31 788 21 69
info@xvivogroup.com

 

Report a violations or breach here: Whistleblower

  • Home
  • Technology
  • Products
  • Knowledge
  • Media
  • About us
  • Corporate

Copyright © 2023 XVIVO. All rights reserved.

Design mkmedia
To top

We use cookies to improve the user experience on XVIVO. Read more about Cookies

Approve